EyePoint Pharmaceuticals (NASDAQ:EYPT) is set to give its latest quarterly earnings report on Wednesday, 2026-03-04. Here’s what investors need to know before the announcement.
Analysts estimate that EyePoint Pharmaceuticals will report an earnings per share (EPS) of $-0.76.
The market awaits EyePoint Pharmaceuticals’s announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It’s important for new investors to understand that guidance can be a significant driver of stock prices.
Performance in Previous Earnings
During the last quarter, the company reported an EPS missed by $0.08, leading to a 0.59% increase in the share price on the subsequent day.
Here’s a look at EyePoint Pharmaceuticals’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.77 | -0.75 | -0.55 | -0.48 |
| EPS Actual | -0.85 | -0.85 | -0.65 | -0.64 |
| Price Change % | 0.59 | -4.82 | 0.16 | 3.65 |
Market Performance of EyePoint Pharmaceuticals’s Stock
Shares of EyePoint Pharmaceuticals were trading at $18.34 as of March 02. Over the last 52-week period, shares are up 173.9%. Given that these …